Early research (Phase 1)Study completedNCT01478503
What this trial is testing
To Evaluate the Blood and Urine Concentration and the Safety and Tolerability of Increasing Repeated Doses of Mirabegron (YM178) OCAS in Healthy Young and Elderly Males and Healthy Young and Elderly Females
Who this might be right for
PharmacokineticsHealthy Subjects
Astellas Pharma Inc 96